financetom
Business
financetom
/
Business
/
SSV Ramakumar gets extension as Director (R&D) on Indian Oil Corporation Board
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
SSV Ramakumar gets extension as Director (R&D) on Indian Oil Corporation Board
Jan 28, 2022 9:28 AM

The government has extended the tenure of S S V Ramakumar, Director (Research & Development), Indian Oil Corporation for 18 months till July 2023, the company said on Friday. Ramakumar was appointed Director (R&D) on IOC board for an initial five-year term beginning February 1, 2017. He was eligible for an extension till his superannuation age of 60 years, which has now been granted.

Share Market Live

NSE

"The Appointments Committee of Cabinet (ACC) has approved the extension of Dr SSV Ramakumar as Director (Research & Development), IOC with effect from February 1, 2022 to July 31, 2023 i.e. the date of his superannuation," the company said in a statement.

An alumnus of IIT-Roorkee, Ramakumar has more than three decades of rich and versatile experience in research, development and deployment in the downstream hydrocarbons sector, notably in the areas of lubricant technology, refinery process research streams, catalyst development and nanotechnology.

"As a champion of alternate energy technologies, he is stewarding IOC R&D's journey as one of the coveted research institutes in the country pioneering the development of new and innovative technologies. Currently, he is helming an ambitious project of constructing the world's largest renewable energy research centre of IOC with net-zero power and water credentials," it said. With his experience and stature, Ramakumar is regarded as a leading voice in the industry on matters spanning the entire energy portfolio.

He has been co-opted by the central government several times to lead or be part of key policy committees to draw the road map for India's smooth transition to a non-fossilized economy in the years to come.

First Published:Jan 28, 2022 6:28 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BRIEF-Suke Anticipate IPO Price Per Ordinary Share Will Be Between $4.00 And $5.00
BRIEF-Suke Anticipate IPO Price Per Ordinary Share Will Be Between $4.00 And $5.00
Nov 6, 2025
Nov 6 (Reuters) - Suke Ltd: * SUKE LTD: ANTICIPATE IPO PRICE PER ORDINARY SHARE WILL BE BETWEEN $4.00 AND $5.00 * SUKE LTD: SEES US IPO OF 1.5 MILLION ORDINARY SHARES - SEC FILING * SUKE LTD: IN ADDITION, 1.8 MILLION ORDINARY SHARES WILL BE OFFERED FOR POTENTIAL RESALE BY SELLING SHAREHOLDERS Source text: Further company coverage: ...
DuPont forecasts downbeat Q4 results to reflect Qnity spinoff, Aramids sale
DuPont forecasts downbeat Q4 results to reflect Qnity spinoff, Aramids sale
Nov 6, 2025
(Reuters) -Industrial materials maker DuPont ( DD ) forecast current-quarter sales and adjusted profit below Wall Street estimates on Thursday to reflect the planned spinoff of its Qnity electronics unit and Aramids business divestiture. The Wilmington, Delaware-based company has been undergoing a strategic reorganization and attempting to streamline its portfolio as the chemicals industry grapples with higher feedstock and energy...
Prestige Consumer Heathcare beats Q2 revenue expectations, tightens FY forecast 
Prestige Consumer Heathcare beats Q2 revenue expectations, tightens FY forecast 
Nov 6, 2025
Overview * Prestige Q2 revenue of $274.1 mln beats analyst expectations despite a 3.4% decline yr/yr * Adjusted EPS of $1.07 for Q2 beats analyst estimates * Company repurchased 1.1 mln shares in Q2, enhancing shareholder value Outlook * Prestige maintains fiscal 2026 revenue outlook at $1,100 mln to $1,115 mln * Company tightens fiscal 2026 adjusted EPS outlook to...
EPAM Q3 revenue beats estimates, announces new $1 bln share repurchase plan
EPAM Q3 revenue beats estimates, announces new $1 bln share repurchase plan
Nov 6, 2025
Overview * Epam ( EPAM ) Q3 revenue grows 19.4% yr/yr, slightly beating analyst expectations * Adjusted EPS for Q3 beats consensus, reflecting strong operational performance * Company announces new $1 bln share repurchase plan Outlook * EPAM ( EPAM ) raises full-year revenue guidance to $5.430 bln-$5.445 bln, reflecting 15.0% growth * Company increases full-year GAAP EPS forecast to...
Copyright 2023-2026 - www.financetom.com All Rights Reserved